首页> 美国卫生研究院文献>Autophagy >The MAPK1/3 pathway is essential for the deregulation of autophagy observed in G2019S LRRK2 mutant fibroblasts
【2h】

The MAPK1/3 pathway is essential for the deregulation of autophagy observed in G2019S LRRK2 mutant fibroblasts

机译:MAPK1 / 3通路对于G2019S LRRK2突变成纤维细胞中观察到的自噬失调至关重要

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

The link between the deregulation of autophagy and cell death processes can be essential in the development of several neurodegenerative diseases, such as Parkinson disease (PD). However, the molecular mechanism of deregulation of this degradative process in PD patients is unknown. The leucine-rich repeat kinase 2 (LRRK2) gene is related to PD and its implication in autophagy regulation has been described. Our recent work shows that the presence of the G2019S LRRK2 mutation, one of the most prevalent in LRRK2, is accompanied by a deregulation of autophagy basal levels dependent on the MAPK1/3 (ERK2/1) pathway.
机译:自噬失调与细胞死亡过程之间的联系对于某些神经退行性疾病(如帕金森病(PD))的发展至关重要。但是,PD患者中这种降解过程失控的分子机制尚不清楚。富含亮氨酸的重复激酶2(LRRK2)基因与PD相关,已经描述了其在自噬调节中的意义。我们最近的工作表明,G2019S LRRK2突变(LRRK2中最普遍的突变)的存在伴随着依赖于MAPK1 / 3(ERK2 / 1)途径的自噬基础水平的失控。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号